Attached files
| file | filename |
|---|---|
| EX-99.1 - CHINA-BIOTICS, INC | v163559_ex99-1.htm |
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported): October 23, 2009 (October 21, 2009)
CHINA-BIOTICS,
INC.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
(State or
Other Jurisdiction of Incorporation)
|
333-110733
|
98-0393071
|
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
No.
999 Ningqiao Road
Jinqiao
Export Processing Zone
Pudong,
Shanghai 201206
People’s
Republic of China
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
(86
21) 5834-9748
(Registrant’s
Telephone Number, Including Area Code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2.
below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(b) Effective
October 21, 2009, Mr. Lewis Fan resigned as Chief Financial Officer of
China-Biotics, Inc. (“China-Biotics”). Mr. Fan is leaving
China-Biotics in order to pursue other career opportunities.
(c) Ms.
Eva Yan, the chief administration officer and a director of Shanghai Shining
Biotechnology Co. Ltd. (“Shining”), a subsidiary of China-Biotics, has been
appointed as interim Chief Financial Officer, effective October 21,
2009. She will serve as interim Chief Financial Officer until a
successor can be appointed. Ms. Yan has served as a director of
Shining since 1999. She was appointed as the chief administration officer of
Shining in 2004. During the past five years, Ms. Yan has been an employee of
China-Biotics in various capacities and has, among other things, participated in
formulating the company’s development plans, controlled the company’s cash flow,
implemented the company’s internal control procedures and represented the
company in business negotiations with relevant government authorities and other
external parties. Ms. Yan will receive a salary of $5,000 per
month as interim Chief Financial Officer.
A press
release related to Mr. Fan’s resignation and Ms. Yan’s appointment is attached
as Exhibit 99.1 to this Current Report on Form 8-K.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit
|
||
|
Number
|
Exhibit Description
|
|
|
99.1
|
Press
Release of China-Biotics, Inc. dated October 23,
2009
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
| CHINA-BIOTICS, INC. | |||
|
Date: October
23, 2009
|
By:
|
/s/ Song Jinan | |
| Song Jinan | |||
| Chief Executive Officer, President, Treasurer and Secretary | |||